AU2007267801A1 - Administration of the REG1 anticoagulation system - Google Patents
Administration of the REG1 anticoagulation system Download PDFInfo
- Publication number
- AU2007267801A1 AU2007267801A1 AU2007267801A AU2007267801A AU2007267801A1 AU 2007267801 A1 AU2007267801 A1 AU 2007267801A1 AU 2007267801 A AU2007267801 A AU 2007267801A AU 2007267801 A AU2007267801 A AU 2007267801A AU 2007267801 A1 AU2007267801 A1 AU 2007267801A1
- Authority
- AU
- Australia
- Prior art keywords
- aptamer
- dose
- antidote
- aptt
- anticoagulant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013263868A AU2013263868A1 (en) | 2006-05-26 | 2013-12-02 | Administration of the REG1 anticoagulation system |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80898706P | 2006-05-26 | 2006-05-26 | |
| US60/808,987 | 2006-05-26 | ||
| US84780906P | 2006-09-27 | 2006-09-27 | |
| US60/847,809 | 2006-09-27 | ||
| US86535206P | 2006-11-10 | 2006-11-10 | |
| US60/865,352 | 2006-11-10 | ||
| PCT/US2007/012625 WO2007140000A2 (en) | 2006-05-26 | 2007-05-25 | Administration of the reg1 anticoagulation system |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2013263868A Division AU2013263868A1 (en) | 2006-05-26 | 2013-12-02 | Administration of the REG1 anticoagulation system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2007267801A1 true AU2007267801A1 (en) | 2007-12-06 |
Family
ID=38779273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007267801A Abandoned AU2007267801A1 (en) | 2006-05-26 | 2007-05-25 | Administration of the REG1 anticoagulation system |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090048193A1 (ru) |
| EP (1) | EP2026653A4 (ru) |
| JP (2) | JP2009538325A (ru) |
| KR (1) | KR20090015118A (ru) |
| CN (1) | CN101453891B (ru) |
| AU (1) | AU2007267801A1 (ru) |
| CA (1) | CA2653313A1 (ru) |
| IL (1) | IL194991A0 (ru) |
| RU (1) | RU2568579C2 (ru) |
| WO (1) | WO2007140000A2 (ru) |
| ZA (1) | ZA200809575B (ru) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2682580A1 (en) * | 2007-03-30 | 2008-10-09 | Duke University | A method of modulating the activity of a nucleic acid molecule |
| US8318923B2 (en) * | 2009-06-03 | 2012-11-27 | Regado Biosciences, Inc. | Nucleic acid modulators of glycoprotein VI |
| US8889645B2 (en) | 2009-06-03 | 2014-11-18 | Regado Biosciences, Inc. | Nucleic acid modulators of glycoprotein VI |
| US8889646B2 (en) | 2009-06-03 | 2014-11-18 | Regado Biosciences, Inc. | Nucleic acid modulators of glycoprotein VI |
| AR077405A1 (es) | 2009-07-10 | 2011-08-24 | Sanofi Aventis | Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer |
| FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
| IN2012DN02345A (ru) | 2009-09-16 | 2015-08-21 | Univ Duke | |
| TWI649095B (zh) * | 2012-02-10 | 2019-02-01 | 捷百克股份有限公司 | 以非人類幹細胞之培養上清液為起始材料之化妝品或皮膚再生促進劑、及蛋白質之離子導入法 |
| SG11201500232UA (en) | 2012-07-13 | 2015-04-29 | Wave Life Sciences Pte Ltd | Chiral control |
| FR3011250A1 (fr) * | 2013-09-30 | 2015-04-03 | Lab Francais Du Fractionnement | Acides nucleiques se liant specifiquement au facteur ix/ixa humain, et utilisations |
| US10066323B2 (en) | 2014-04-16 | 2018-09-04 | Duke University | Electrospun cationic nanofibers and methods of making and using the same |
| US10660973B2 (en) | 2015-04-28 | 2020-05-26 | Duke University | Thrombus imaging aptamers and methods of using same |
| WO2018053427A1 (en) | 2016-09-16 | 2018-03-22 | Duke University | Von willebrand factor (vwf)-targeting agents and methods of using the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19935303A1 (de) * | 1999-07-28 | 2001-02-08 | Aventis Pharma Gmbh | Oligonukleotide zur Inhibierung der Expression von humanem eg5 |
| DK1401853T3 (da) * | 2001-05-25 | 2010-11-01 | Univ Duke | Modulatorer af farmakologiske midler |
| SI1745062T1 (sl) * | 2004-04-22 | 2014-09-30 | Regado Biosciences, Inc. | Izobljšani modulatorji koagulacijskih faktrojev |
-
2007
- 2007-05-25 US US11/805,950 patent/US20090048193A1/en not_active Abandoned
- 2007-05-25 JP JP2009512183A patent/JP2009538325A/ja not_active Withdrawn
- 2007-05-25 RU RU2012136951/15A patent/RU2568579C2/ru not_active IP Right Cessation
- 2007-05-25 KR KR1020087030333A patent/KR20090015118A/ko not_active Application Discontinuation
- 2007-05-25 WO PCT/US2007/012625 patent/WO2007140000A2/en active Application Filing
- 2007-05-25 CN CN2007800194058A patent/CN101453891B/zh not_active Expired - Fee Related
- 2007-05-25 CA CA002653313A patent/CA2653313A1/en not_active Abandoned
- 2007-05-25 EP EP07815043A patent/EP2026653A4/en not_active Withdrawn
- 2007-05-25 AU AU2007267801A patent/AU2007267801A1/en not_active Abandoned
-
2008
- 2008-10-30 IL IL194991A patent/IL194991A0/en unknown
- 2008-11-10 ZA ZA2008/09575A patent/ZA200809575B/en unknown
-
2014
- 2014-03-19 JP JP2014055961A patent/JP2014148515A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| KR20090015118A (ko) | 2009-02-11 |
| JP2014148515A (ja) | 2014-08-21 |
| RU2568579C2 (ru) | 2015-11-20 |
| EP2026653A2 (en) | 2009-02-25 |
| JP2009538325A (ja) | 2009-11-05 |
| CN101453891A (zh) | 2009-06-10 |
| CN101453891B (zh) | 2013-12-11 |
| US20090048193A1 (en) | 2009-02-19 |
| ZA200809575B (en) | 2015-04-29 |
| EP2026653A4 (en) | 2011-11-16 |
| IL194991A0 (en) | 2009-08-03 |
| RU2012136951A (ru) | 2014-03-10 |
| CA2653313A1 (en) | 2007-12-06 |
| WO2007140000A2 (en) | 2007-12-06 |
| WO2007140000A3 (en) | 2008-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090048193A1 (en) | Administration of the REG1 anticoagulation system | |
| US8859518B2 (en) | Modulators of coagulation factors | |
| EP1401853B1 (en) | Modulators of pharmacological agents | |
| AU2010256511B2 (en) | Nucleic acid modulators of glycoprotein VI | |
| US20090163437A1 (en) | Steady-state subcutaneous administration of aptamers | |
| JP2023093535A (ja) | フォン・ヴィレブランド因子に関連する合併症及び障害の処置のための組成物及び方法 | |
| AU2013263868A1 (en) | Administration of the REG1 anticoagulation system | |
| RU2464030C2 (ru) | Введение противосвертывающей системы reg1 | |
| UA94948C2 (en) | Administration of the reg1 anticoagulation system | |
| AU2012244176B8 (en) | Modulators of pharmacological agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |